文献速递肥胖与代谢综合征糖尿病

血浆ANGPTL8水平的遗传与代谢决定因素

Genetic and Metabolic Determinants of Plasma Levels of ANGPTL8.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

基于达拉斯心脏研究人群(DHS-1 n=3538;DHS-2 n=3283,其中2131人相隔7-9年重复测量),使用新ELISA法检测血浆ANGPTL8(A8)水平。A8水平跨度达150倍(2.1-318 ng/mL,中位数13.3 ng/mL),存在种族差异(黑人>西班牙裔>白人),与BMI、空腹血糖、胰岛素和TG相关;A8基因变异R59W解释17%的个体间变异,但与上述代谢参数无关,提示A8水平差异与代谢表型无因果关系。

要点

  • 血浆A8水平个体间差异达150倍,且存在种族差异。
  • A8水平与BMI、空腹血糖、胰岛素和TG水平相关。
  • A8基因变异R59W解释17%的A8水平变异,但不与代谢参数相关,提示非因果。

核心结论

  • A8水平与糖和TG代谢指标强相关,但影响A8水平的遗传变异与这些指标无关,提示A8水平差异与相关代谢表型并非因果相关。

研究设计与样本

  • 基于达拉斯县人群的达拉斯心脏研究(DHS-1 n=3538;DHS-2 n=3283),包括2131名相隔7至9年重复测量的个体(年龄18-85岁;女性>55%;黑人52%;白人29%;西班牙裔17%;其他2%)。
  • 使用新开发的酶联免疫吸附试验(ELISA)检测血浆A8水平,并通过外显子组测序鉴定DNA变异。

主要发现

  • A8水平变化范围达150倍(2.1-318 ng/mL;中位数13.3 ng/mL),且在不同种族/族裔群体间存在差异(黑人>西班牙裔>白人)。
  • A8水平与BMI、空腹血糖、胰岛素和TG水平相关。
  • A8基因变异R59W解释了17%的A8水平个体间变异,但与血浆A8浓度相关的代谢参数无关。

临床怎么用

  • 血浆A8水平与糖脂代谢指标相关,但当前证据不支持其作为这些代谢表型的因果标志物。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: ANGPTL8 (A8) plays a key role in determining the tissue fate of circulating triglycerides (TGs). Plasma A8 levels are associated with several parameters of glucose and TG metabolism, but the causality of these relationships and the contribution of genetic variants to differences in A8 levels have not been explored. OBJECTIVE: To characterize the frequency distribution of plasma A8 levels in a diverse population using a newly-developed enzyme-linked immunosorbent assay (ELISA) and to identify genetic factors contributing to differences in plasma A8 levels. METHODS: We studied a population-based sample of Dallas County, comprising individuals in the Dallas Heart Study (DHS-1, n = 3538; DHS-2, n = 3283), including 2131 individuals with repeated measurements 7 to 9 years apart (age 18-85 years; >55% female; 52% Black; 29% White; 17% Hispanic; and 2% other). The main outcome measures were associations of A8 levels with body mass index (BMI), plasma levels of glucose, insulin, lipids, and hepatic TGs, as well as DNA variants identified by exome-wide sequencing. RESULTS: A8 levels varied over a 150-fold range (2.1-318 ng/mL; median, 13.3 ng/mL) and differed between racial/ethnic groups (Blacks > Hispanics > Whites). A8 levels correlated with BMI, fasting glucose, insulin, and TG levels. A variant in A8, R59W, accounted for 17% of the interindividual variation in A8 levels but was not associated with the metabolic parameters correlated with plasma A8 concentrations. CONCLUSIONS: A8 levels were strongly associated with indices of glucose and TG metabolism, but the lack of association of genetic variants at the A8 locus that impact A8 levels with these parameters indicates that differences in A8 levels are not causally related to the associated metabolic phenotypes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Oldoni F, Bass K, Kozlitina J, et al. Genetic and Metabolic Determinants of Plasma Levels of ANGPTL8. J Clin Endocrinol Metab. 2021. PMID: 33619548. doi:10.1210/clinem/dgab120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。